Sivik Global Healthcare LLC / ABT
Sivik Global Healthcare LLC’s Abbott Laboratories Position
Does Sivik Global Healthcare LLC own Abbott Laboratories (ABT)? Yes — 25.0K shares worth $3M (+1.95% of its 13F portfolio) as of Q1 2026, down from 40.0K shares the prior filed quarter.
Position Value
$3M
Q1 2026
Shares
25.0K
% of Portfolio
+1.95%
Quarters Held
28
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 25.0K | $3M | +1.95% |
| Q4 2025 | 40.0K | $5M | +1.45% |
| Q3 2025 | 37.5K | $5M | +1.46% |
| Q2 2025 | 39.2K | $5M | +1.45% |
| Q1 2025 | 45.0K | $6M | +3.23% |
| Q4 2024 | 50.0K | $6M | +2.98% |
| Q3 2024 | 60.0K | $7M | +2.90% |
| Q1 2024 | 50.0K | $6M | +1.33% |
| Q4 2023 | 52.5K | $6M | +2.41% |
| Q2 2023 | 60.0K | $7M | +1.53% |
| Q1 2023 | 45.0K | $5M | +1.96% |
| Q4 2022 | 45.0K | $5M | +2.32% |
| Q3 2022 | 30.0K | $3M | +1.61% |
| Q2 2022 | 40.0K | $4M | +2.47% |
| Q1 2022 | 45.0K | $5M | +2.20% |
| Q4 2021 | 50.0K | $7M | +3.02% |
| Q3 2021 | 70.0K | $8M | +1.98% |
| Q2 2021 | 50.0K | $6M | +1.13% |
| Q1 2021 | 65.0K | $8M | +2.84% |
| Q4 2020 | 75.0K | $8M | +3.35% |
| Q3 2020 | 90.0K | $10M | +4.21% |
| Q2 2020 | 25.0K | $2M | +0.64% |
| Q1 2020 | 65.0K | $5M | +1.97% |
| Q4 2019 | 60.0K | $5M | +1.93% |
| Q3 2019 | 80.0K | $7M | +3.38% |
| Q2 2019 | 80.0K | $7M | +1.63% |
| Q1 2019 | 100.0K | $8M | +2.95% |
| Q4 2018 | 115.0K | $8M | +4.48% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sivik Global Healthcare LLC’s full portfolio or all institutional holders of ABT.